Abstract
To prevent respiratory virus (RV) infection after hematopoietic SCT (HSCT), patient and household members are advised to have annual influenza vaccinations and avoid symptomatic contacts. The object of this study was to measure and increase patient/household awareness of RV infection and preventive measures. We used a self-administered questionnaire before/after a 5-min educational module (2006–2007) and interviews with HSCT patients (2005–2007). The subjects were patients and their households attending pre-HSCT education in an Australian HSCT Unit. Outcome measures were awareness of RV infection post-HSCT and effective prevention strategies; household influenza vaccination on admission for HSCT. In all, 139 out of 205 (68%) participants completed both questionnaires. Baseline knowledge of RV infection risk was high; knowledge of prevention was low. Intervention increased awareness that influenza post-HSCT could be fatal or require intensive care (68–87%, P=0.003), knowledge of effective prevention strategies (41–78%, P<0.0001) including vaccination (11–58%, P<0.0001), and belief among family/friends (but not patients) that household vaccination reduces influenza risk post-HSCT (57–97%, P<0.0001 and 76–81%, P=0.2, respectively). Household vaccination at HSCT admission was 71% for attenders and 30% for non-participants (RR 2.38, 95% confidence interval (CI) 1.49–3.80, P<0.0001). We concluded that patient and family pre-HSCT education increases awareness of RV prevention strategies and household influenza vaccination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roghmann M, Ball K, Erdmann D, Lovchik J, Anderson LJ, Edelman R . Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 32: 1085–1088.
van Kraaij MGJ, van Elden LJR, van Loom AM, Hendriksen KA, Laterveer L, Dekker AW et al. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis 2005; 40: 662–669.
Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Am Soc Blood Marrow Transplant 2005; 11: 781–796.
Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.
Couch RB, Englund JA, Whimbey E . Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102: 2–9.
Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778–782.
Nichols WG, Guthrie KA, Corey L, Boeckh M . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300–1306.
Machado CM, Boas LSV, Mendes AVA, da Rocha IF, Sturaro D, Dulley FL et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 111–114.
Moscona A . Global transmission of oseltamivir-resistant influenza. N Engl J Med 2009; 360: 953–956.
Ison MG, Gubareva LV, Atmar RL, Treanor JJ, Hayden FG . Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2007; 193: 760–764.
Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009; 301: 1042–1046.
van der Vries E, van den Berg B, Schutten M . Fatal oseltamivir-resistant influenza virus infection. N Engl J Med 2008; 359: 1074–1076.
DiMecheli V, Rivetti D, Deeks JJ, Jefferson TO . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews 2004, Issue no. 3, Art. no.: CD001269.
Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 2001; 28: 775–781.
Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 2001; 28: 775–781.
Backer H . Counterpoint: in favor of mandatory influenza vaccine for all health care workers. Clin Infect Dis 2006; 42: 1144–1147.
Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 52(RR-8). Morbidity & Mortality Weekly Report Recommendations & Reports, 2003, pp 1–34.
Australian Technical Advisory Group on Immunisation, Australian Government Department of Health and Aging. The Australian Immunisation Handbook, 9th edn. National Health and Medical Research Council of Australia: Canberra, 2008, pp 190–193.
Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737–746.
National Centre for Infectious Diseases, Centers for Disease Control and Prevention. Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients: Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation, 49(RR-10). Centre for Disease Control and Prevention. Morbidity and Mortality Weekly Report, 2000, pp 1–128.
Kirscht JP, Don PH, Kegeles SS, Rosenstock IM . A National Study of Health Beliefs. J Health Hum Behav 1966; 7: 248–254.
Glanz K, Rimer BK . Theory at a Glance: A Guide for Health Promotion, 2nd edn. NIH Publication No. 05-389. National Cancer Institute, National Institutes of Health, US Department of Health and Human Services: Washington, DC, 2005.
Stead LF, Bergson G, Lancaster T . Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue no. 2, Art. no.: CD000165.
Mac Donald R, Baken L, Nelson A, Nichol KL . Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999; 16: 173–177.
Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007; 25: 4775–4783.
Centre for Epidemiology and Research. Vaccinated against influenza in the last 12 months by age, persons aged 65 years and over, NSW, 2006. In: 2007 Report on Adult Health from the New South Wales Population Health Survey. NSW Department of Health: Sydney, 2008.
Joseph C, Goddard N . Influenza vaccine uptake in the elderly: results from a rapid assessment of the effectiveness of new government policy in England for the winters 2000/2001 and 2001/2002. Vaccine 2003; 21: 1137–1148.
Chi R-C, Reiber GE, Neuzil KM . Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system. J Am Geriatr Soc 2006; 54: 217–223.
Acknowledgements
We thank Mary McGurgan for coordinating the education forums, Masrura Kabir for database design, Tania Sorrell for review of paper, and the patients and families involved in this study. This study was supported by the National Health and Medical Research Council of Australia (NHMRC) through a Centre of Clinical Research Excellence Grant (# 264625), and through a NHMRC post-graduate medical award to PEF. All researchers were independent of the funder. PEF designed and executed the study, analysed results, did the principal writing, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. CFCJ and NMG contributed to study design, interpretation of results and writing of the paper. The NHMRC Clinical Centre for Research Excellence in Bioethics and Haematological Malignancies is funded by the National Health and Medical Research Council, Department of Health, Australian Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferguson, P., Jordens, C. & Gilroy, N. Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention. Bone Marrow Transplant 45, 656–661 (2010). https://doi.org/10.1038/bmt.2009.209
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.209